 DLNS-1RBD4NDAFLAIVs are a promising next-generation vaccine candidate for controlling SARS-CoV-2 infection and preventing its spread. It has been shown to be effective in protecting against multiple strains of the virus, including Delta and Armacron BA.2, and can potentially be used as part of an annual vaccination strategy to combat both influenza and COVID-19. This article was authored by Xiaofeng Deng, Ying Liu, Rachel Chun-Yi Tam, and others.